Brown Tumors Mimicking Diffuse Skeletal Metastases on F-18 FDG PET/CT and Bone Scintigraphy

Brown tumors are rare benign skeletal manifestations of hyperparathyroidism that may demonstrate intense 18F-FDG uptake and mimic metastatic bone disease on PET/CT. We report a case of primary hyperparathyroidism with markedly elevated parathyroid hormone levels and hypercalcemia. Prior Tc-99m sestamibi dual-phase parathyroid scintigraphy with subtraction imaging demonstrated persistent radiotracer retention in the right inferior parathyroid region, consistent with parathyroid adenoma. Bone scintigraphy suggested a metabolic bone process rather than metastatic disease, whereas subsequent 18F-FDG PET/CT revealed multiple intensely hypermetabolic skeletal lesions concerning for widespread metastases. In contrast, the suspected parathyroid lesion showed relatively low FDG uptake. Correlation of multimodality nuclear imaging findings with biochemical parameters favored the diagnosis of brown tumors, which was confirmed histopathologically as parathyroid adenoma. This case highlights the importance of integrating PET/CT, scintigraphic, and laboratory findings to avoid misinterpretation of FDG-avid skeletal lesions and unnecessary oncologic management.

Authors

Institutions

Publication Details

Journal
Molecular Oncologic Imaging
Published
2026-07-30
DOI
https://doi.org/10.71286/moi.1957104
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Brown Tumors Mimicking Diffuse Skeletal Metastases on F-18 FDG PET/CT and Bone Scintigraphy

Ali Çiçekli, Ayşe Rana Övüt
Molecular Oncologic Imaging
Parathyroid Disorders and Treatments
article

Brown Tumors Mimicking Diffuse Skeletal Metastases on F-18 FDG PET/CT and Bone Scintigraphy

Ali Çiçekli, Ayşe Rana Övüt
article en

Abstract

Brown tumors are rare benign skeletal manifestations of hyperparathyroidism that may demonstrate intense 18F-FDG uptake and mimic metastatic bone disease on PET/CT. We report a case of primary hyperparathyroidism with markedly elevated parathyroid hormone levels and hypercalcemia. Prior Tc-99m sestamibi dual-phase parathyroid scintigraphy with subtraction imaging demonstrated persistent radiotracer retention in the right inferior parathyroid region, consistent with parathyroid adenoma. Bone scintigraphy suggested a metabolic bone process rather than metastatic disease, whereas subsequent 18F-FDG PET/CT revealed multiple intensely hypermetabolic skeletal lesions concerning for widespread metastases. In contrast, the suspected parathyroid lesion showed relatively low FDG uptake. Correlation of multimodality nuclear imaging findings with biochemical parameters favored the diagnosis of brown tumors, which was confirmed histopathologically as parathyroid adenoma. This case highlights the importance of integrating PET/CT, scintigraphic, and laboratory findings to avoid misinterpretation of FDG-avid skeletal lesions and unnecessary oncologic management.

Molecular Oncologic ImagingVol. 6(2)
İstanbul Eğitim ve Araştırma Hastanesi (TR), Mustafa Kemal University (TR)
Good health and well-being
Openalex Percentile: Top 10%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.